US EditionPublished • loading... • Updated
Cardiovalve Submits CE File for Approval Following Successful TARGET Study Completion
Summary by Cardiovascular News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
TARGET study demonstrates TR reduction with Cardiovalve system
Georg Nickenig Venus Medtech has announced the submission of technical files for CE mark approval of the Cardiovalve transcatheter tricuspid valve replacement (TTVR) system, following completion of the TARGET study assessing the safety and performance of the device in 150 patients. Taking place across 30 sites in Europe, the UK, and Canada the prospective, single-arm, open-label, multicentre clinical trial was designed to evaluate the safety and…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
